EGFR and neoplasm: FFJ-5, a naphthoquinone modifier of mollugin, attenuates the expression of PKM2 and reduces the production of ATP via blocking the EGFR-Akt-PKM2 pathway, which eventually induces tumor cell apoptosis [83].